N

Nektar Therapeutics
D

NKTR

0.90010
USD
-0.02
(-2.16%)
Market Open
Volume
25,755
EPS
-1
Div Yield
-
P/E
-1
Market Cap
166,030,901
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    AMGN
    -2.09
    (-0.79%)
    261.38 USD
    AZN
    AZN
    0.460
    (0.70%)
    65.870 USD
    BIIB
    BIIB
    1.390
    (0.95%)
    147.980 USD
    BMY
    BMY
    -0.300
    (-0.52%)
    56.980 USD
    GILD
    GILD
    0.150
    (0.16%)
    92.720 USD
    I
    INCY
    0.040
    (0.06%)
    68.950 USD
    LLY
    LLY
    12.62
    (1.64%)
    781.00 USD
    MRK
    MRK
    0.510
    (0.52%)
    98.680 USD
    PFE
    PFE
    0.005
    (0.02%)
    26.390 USD
    REGN
    REGN
    8.19
    (1.17%)
    710.79 USD
    More
News

Title: Nektar Therapeutics

Sector: Healthcare
Industry: Biotechnology
Nektar Therapeutics is a pharmaceutical company focused on the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. The company is focused on discovering and developing medicines in the field of immunotherapy. Its clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases (e.g. rezpegaldesleukin and NKTR-0165, respectively) and cancer (e.g. NKTR-255).